Merus N.V.

Merus N.V. is a biotechnology company focused on discovering and developing innovative cancer treatments using its proprietary Multiclonics® platform. Committed to accelerating clinical trials and delivering new therapies, Merus aims to improve outcomes for cancer patients worldwide.